|
Almeida Capital is pleased to be a premier sponsor of AltAssets
|
FREE newsletter RSS
INTELLIGENCE
RECRUITMENT
KNOWLEDGE BANK
EVENTS
SECTOR ANALYSIS
HEDGE FUNDS
|
Click here for printer friendly page
Hatteras's third venture capital fund holds first closing12/02/2007. Source: AltAssets. 
 Hatteras Venture Partners III has held a first closing on $60m. The fund will invest in seed and early stage companies in biopharmaceuticals, medical devices, diagnostics and related opportunities in human medicine. The fund is expected to close on $100m.
HVP III may invest in opportunities throughout the US but will focus on investments in the Southeastern part of the country.
'When you analyse the different regions of the country, you see significant federal and private research dollars flowing into laboratories in the Southeast,' said HVP general partner Clay Thorp. 'At the same time, venture capital flows into Southeastern companies are much lower than in California and Massachusetts. This capital gap represents a tremendous investment opportunity.'
Hatteras Venture Partners launched its first fund, Hatteras Venture Partners I, a pre-seed fund that focused predominantly on company formation in the life sciences, in 2000. In 2004 the firm raised its second fund, Hatteras Venture Partners II, a later stage fund invested through a partnership with HBM BioCapital.
With its three funds, Hatteras now has more than $100m under management.
Copyright © 2007 AltAssets
|
 
|
|
|
